INSM INSMED Inc

Price (delayed)

$25.77

Market cap

$3.09B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.51

Enterprise value

$3.51B

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved ...

Highlights
The company's gross profit rose by 32% YoY and by 9% QoQ
INSM's revenue is up by 30% year-on-year and by 10% since the previous quarter
INSMED's net income has decreased by 11% YoY but it has increased by 5% QoQ
The equity has plunged by 92% YoY and by 63% from the previous quarter
The company's quick ratio fell by 46% YoY and by 2.8% QoQ

Key stats

What are the main financial stats of INSM
Market
Shares outstanding
119.98M
Market cap
$3.09B
Enterprise value
$3.51B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
69.62
Price to sales (P/S)
13.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.85
Earnings
Revenue
$221.21M
EBIT
-$388.45M
EBITDA
-$376.8M
Free cash flow
-$374.27M
Per share
EPS
-$3.51
Free cash flow per share
-$3.13
Book value per share
$0.37
Revenue per share
$1.85
TBVPS
$7.07
Balance sheet
Total assets
$1.05B
Total liabilities
$1.01B
Debt
$830.56M
Equity
$44.24M
Working capital
$560.91M
Liquidity
Debt to equity
18.77
Current ratio
5.93
Quick ratio
5.13
Net debt/EBITDA
-1.1
Margins
EBITDA margin
-170.3%
Gross margin
76.5%
Net margin
-188%
Operating margin
-172.2%
Efficiency
Return on assets
-34.9%
Return on equity
-154.1%
Return on invested capital
-40.6%
Return on capital employed
-41.3%
Return on sales
-175.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INSM stock price

How has the INSMED stock price performed over time
Intraday
-2.72%
1 week
-8.65%
1 month
11.41%
1 year
10.51%
YTD
-5.4%
QTD
30.68%

Financial performance

How have INSMED's revenue and profit performed over time
Revenue
$221.21M
Gross profit
$169.15M
Operating income
-$380.84M
Net income
-$415.96M
Gross margin
76.5%
Net margin
-188%
The company's gross profit rose by 32% YoY and by 9% QoQ
INSM's revenue is up by 30% year-on-year and by 10% since the previous quarter
INSMED's operating income has decreased by 18% YoY
The net margin has grown by 14% YoY and by 13% from the previous quarter

Growth

What is INSMED's growth rate over time

Valuation

What is INSMED stock price valuation
P/E
N/A
P/B
69.62
P/S
13.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.85
The EPS has grown by 7% since the previous quarter and by 2.5% year-on-year
The equity has plunged by 92% YoY and by 63% from the previous quarter
INSM's revenue is up by 30% year-on-year and by 10% since the previous quarter
INSM's price to sales (P/S) is 6% lower than its last 4 quarters average of 14.8

Efficiency

How efficient is INSMED business performance
INSM's ROE is down by 40% YoY and by 38% from the previous quarter
The ROIC has grown by 31% year-on-year and by 14% since the previous quarter
The company's return on assets rose by 17% YoY
The ROS has grown by 12% since the previous quarter and by 12% year-on-year

Dividends

What is INSM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INSM.

Financial health

How did INSMED financials performed over time
INSM's total assets is 4.4% higher than its total liabilities
The company's quick ratio fell by 46% YoY and by 2.8% QoQ
INSMED's total liabilities has increased by 44% YoY but it has decreased by 2.4% from the previous quarter
The debt to equity has soared by 169% from the previous quarter
The equity has plunged by 92% YoY and by 63% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.